409 related articles for article (PubMed ID: 31577659)
21. Breast Reconstruction Following Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Lamaris GA; Butler CE; Deva AK; Miranda RN; Hunt KK; Connell T; Lipa JE; Clemens MW
Plast Reconstr Surg; 2019 Mar; 143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):51S-58S. PubMed ID: 30817556
[TBL] [Abstract][Full Text] [Related]
22. Clinical Implications and Management of Non-BIA-ALCL Breast Implant Capsular Pathology.
Vorstenbosch J; Chu JJ; Ariyan CE; McCarthy CM; Disa JJ; Nelson JA
Plast Reconstr Surg; 2023 Jan; 151(1):20e-30e. PubMed ID: 36194076
[TBL] [Abstract][Full Text] [Related]
23. Breast implant-associated anaplastic large cell lymphoma: review of a distinct clinicopathologic entity.
Xu J; Wei S
Arch Pathol Lab Med; 2014 Jun; 138(6):842-6. PubMed ID: 24878027
[TBL] [Abstract][Full Text] [Related]
24. Breast Implant-Associated Anaplastic Large Cell Lymphoma: Two Distinct Clinical Presentations.
Miranda P; Moita F; Vargas Moniz J; Rodrigues Dos Santos C
Acta Med Port; 2022 Nov; 35(11):835-839. PubMed ID: 35584637
[TBL] [Abstract][Full Text] [Related]
25. Oncological Outcomes After Multidisciplinary Management of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
O'Connell RL; Sharma B; El-Sharkawi D; Wotherspoon A; Attygalle AD; MacNeill F; Khan AA; Tasoulis MK
Ann Surg Oncol; 2023 Oct; 30(10):6170-6175. PubMed ID: 37454017
[TBL] [Abstract][Full Text] [Related]
26. Molecular Drivers of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Blombery P; Thompson ER; Prince HM
Plast Reconstr Surg; 2019 Mar; 143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):59S-64S. PubMed ID: 30817557
[TBL] [Abstract][Full Text] [Related]
27. Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Systematic Review.
Leberfinger AN; Behar BJ; Williams NC; Rakszawski KL; Potochny JD; Mackay DR; Ravnic DJ
JAMA Surg; 2017 Dec; 152(12):1161-1168. PubMed ID: 29049466
[TBL] [Abstract][Full Text] [Related]
28. Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL): an overview of presentation and pathogenesis and guidelines for pathological diagnosis and management.
Jones JL; Hanby AM; Wells C; Calaminici M; Johnson L; Turton P; Deb R; Provenzano E; Shaaban A; Ellis IO; Pinder SE;
Histopathology; 2019 Dec; 75(6):787-796. PubMed ID: 31166611
[TBL] [Abstract][Full Text] [Related]
29. Is Breast Implant-Associated Anaplastic Large Cell Lymphoma Better Classified as a Lymphoproliferative Disorder and How Surgeons Reduce Risk?
Lukavsky RJ; Couto RA; Adams WP
Clin Plast Surg; 2021 Jan; 48(1):71-77. PubMed ID: 33220906
[TBL] [Abstract][Full Text] [Related]
30. Validation of a CD30 Enzyme-Linked Immunosorbant Assay for the Rapid Detection of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Hanson SE; Hassid VJ; Branch-Brooks C; Liu J; Kadin ME; Miranda R; Butler CE; Clemens MW
Aesthet Surg J; 2020 Jan; 40(2):149-153. PubMed ID: 30789639
[TBL] [Abstract][Full Text] [Related]
31. Cell of Origin and Immunologic Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large-Cell Lymphoma.
Turner SD; Inghirami G; Miranda RN; Kadin ME
Am J Pathol; 2020 Jan; 190(1):2-10. PubMed ID: 31610171
[TBL] [Abstract][Full Text] [Related]
32. Breast Implant-associated Anaplastic Large Cell Lymphoma: Review and Multiparametric Imaging Paradigms.
Sharma B; Jurgensen-Rauch A; Pace E; Attygalle AD; Sharma R; Bommier C; Wotherspoon AC; Sharma S; Iyengar S; El-Sharkawi D
Radiographics; 2020; 40(3):609-628. PubMed ID: 32302264
[TBL] [Abstract][Full Text] [Related]
33. Breast implant associated anaplastic large cell lymphoma: The UK experience. Recommendations on its management and implications for informed consent.
Johnson L; O'Donoghue JM; McLean N; Turton P; Khan AA; Turner SD; Lennard A; Collis N; Butterworth M; Gui G; Bristol J; Hurren J; Smith S; Grover K; Spyrou G; Krupa K; Azmy IA; Young IE; Staiano JJ; Khalil H; MacNeill FA
Eur J Surg Oncol; 2017 Aug; 43(8):1393-1401. PubMed ID: 28596034
[TBL] [Abstract][Full Text] [Related]
34. Anaplastic Large-Cell Lymphoma Associated with Breast Implants: A Case Report of a Transgender Female.
Patzelt M; Zarubova L; Klener P; Barta J; Benkova K; Brandejsova A; Trneny M; Gürlich R; Sukop A
Aesthetic Plast Surg; 2018 Apr; 42(2):451-455. PubMed ID: 29101436
[TBL] [Abstract][Full Text] [Related]
35. Recurrent PDL1 expression and PDL1 (CD274) copy number alterations in breast implant-associated anaplastic large cell lymphomas.
Tabanelli V; Corsini C; Fiori S; Agostinelli C; Calleri A; Orecchioni S; Melle F; Motta G; Rotili A; Di Napoli A; Pileri SA
Hum Pathol; 2019 Aug; 90():60-69. PubMed ID: 31125630
[TBL] [Abstract][Full Text] [Related]
36. What's Your Micromort? A Patient-Oriented Analysis of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
Sieber DA; Adams WP
Aesthet Surg J; 2017 Sep; 37(8):887-891. PubMed ID: 29036945
[TBL] [Abstract][Full Text] [Related]
37. Public Perceptions on Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Lee E; Khavanin N; He W; Darrach H; Kraenzlin F; Jenny H; Yang R; Sacks JM
Plast Reconstr Surg; 2020 Jul; 146(1):30-37. PubMed ID: 32590638
[TBL] [Abstract][Full Text] [Related]
38. Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): Are You Covered?
Ha M; Ngaage LM; Zhu K; Hricz N; Slezak S; Rasko YM
Aesthet Surg J; 2021 Nov; 41(12):NP1943-NP1949. PubMed ID: 33856438
[TBL] [Abstract][Full Text] [Related]
39. Breast Implant-Associated Anaplastic Large Cell Lymphoma: Defining Future Research Priorities.
DeCoster RC; Lynch EB; Bonaroti AR; Miranda RN; Hunt KK; Clemens MW
Clin Plast Surg; 2021 Jan; 48(1):33-43. PubMed ID: 33220903
[TBL] [Abstract][Full Text] [Related]
40. Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Rastogi P; Deva AK; Prince HM
Curr Hematol Malig Rep; 2018 Dec; 13(6):516-524. PubMed ID: 30345474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
